According to the latest studies, plasma-derived extracellular vesicles stimulated caspase-3 activity and reduced the rate of survival in human pulmonary microvascular endothelial cells of severe COVID-19 patients (Krishnamachary et al., 2020; Magro et al., 2021). Here, CASP3 is linked to COVID-19.